M&T Bank’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,117
Closed -$72K 1750
2020
Q4
$72K Sell
11,117
-29
-0.3% -$169 ﹤0.01% 1597
2020
Q3
$40K Sell
11,146
-53
-0.5% -$214 ﹤0.01% 1527
2020
Q2
$52K Buy
+11,199
New +$47.6K ﹤0.01% 1487
2020
Q1
Sell
-15,169
Closed -$77K 1720
2019
Q4
$77K Buy
15,169
+770
+5% +$2.61K ﹤0.01% 1330
2019
Q3
$35K Sell
14,399
-25,681
-64% -$68.2K ﹤0.01% 1537
2019
Q2
$87K Buy
40,080
+4,649
+13% +$11K ﹤0.01% 1509
2019
Q1
$96K Buy
+35,431
New +$153K ﹤0.01% 1490
2016
Q1
Sell
-10,164
Closed -$138K 1822
2015
Q4
$138K Sell
10,164
-1,351
-12% -$16.6K ﹤0.01% 1557
2015
Q3
$111K Sell
11,515
-5,299
-32% -$77.5K ﹤0.01% 1614
2015
Q2
$241K Sell
16,814
-2,509
-13% -$27.6K ﹤0.01% 1638
2015
Q1
$174K Buy
19,323
+5,317
+38% +$38.5K ﹤0.01% 1775
2014
Q4
$86K Sell
14,006
-4,870
-26% -$44.5K ﹤0.01% 1886
2014
Q3
$200K Buy
+18,876
New +$214K ﹤0.01% 1891
2013
Q4
Sell
-100
Closed -$2K 1114
2013
Q3
$2K Hold
100
﹤0.01% 987
2013
Q2
$2K Buy
+100
New +$1.62K ﹤0.01% 996

Other funds holding IMGN

M&T Bank's IMGN Position: Q1 2021 in Review

M&T Bank sold out of Immunogen Inc (IMGN) in Q1 2021, closing a stake of 11,117 shares — an estimated $72K sold.

M&T Bank first reported a position in IMGN in Q2 2013 and held it in 15 quarters. The position peaked at $241K in Q2 2015. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2021.

  • M&T Bank reported no remaining Immunogen Inc position as of Q1 2021 after selling out during the quarter.
  • M&T Bank sold 11,117 Immunogen Inc shares in Q1 2021, an estimated $72K.
  • M&T Bank first reported a position in Immunogen Inc in Q2 2013 and held it in 15 quarters.
  • M&T Bank's Immunogen Inc position peaked at $241K in Q2 2015.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2021.

Based on M&T Bank's 13F filing for Q1 2021, filed 6 May 2021.